N-Acetyl Cysteine para Depression-Related Cognitive Dysfunction

Research suggests NAC's glutamate modulation and glutathione restoration may help address cognitive aspects of depression. Evidence is emerging from several clinical studies exploring NAC as an adjunctive treatment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Ddepression\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Conclusão

Key Study Findings

Review

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

Dose: None vs: None Outcome: None Efeito: None None

População: restless legs syndrome

Review

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Dose: None vs: None Outcome: None Efeito: None None

População: None

Other n=24 2 weeks

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging.

Dose: NAC 100 mg/kg body weight orally daily for 14 days vs: Placebo Efeito: significant augmentation of antioxidants and reduction of prooxidants in old rats; downregulation of None

Review

Restless legs syndrome.

Dose: None vs: None Outcome: quality of life Efeito: None None

População: cardiovascular patients

In Vitro

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Dose: Valerian extract and valerenic acid vs: LSD binding Outcome: 5-HT5a receptor binding affinity Efeito: PE extract IC50 15.7 ng/ml (high affinity) None

População: None

Key Statistics

Estudos

400

Participantes

↑

Positive

Nota

Referenced Papers

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Review

Sleep medicine clinics 2021 14 citações

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Review

Neuroscience and biobehavioral … 2019 45 citações

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Other

Canadian journal of … 2018 37 citações

Restless legs syndrome. Review

Handbook of clinical … 2011 8 citações

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:: 600-1,800 mg/day
neuroprotection:: 1,200-2,400 mg/day

Limite superior: Not established as supplement; 6,000+ mg/day used clinically (IV)

Dosagens Estudadas em Pesquisas

Dosagem	Duração	Efeito	N
None	--	Mixed	--
None	--	Positive	--
NAC 100 mg/kg body weight orally daily for 14 days	2 weeks	Positive	24
None	--	Mixed	--
Valerian extract and valerenic acid	--	Positive	--

Melhor horário: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Efeitos Colaterais Relatados

⚠ Nausea and vomiting
⚠ Diarrhea
⚠ Unpleasant sulfur taste/smell
⚠ Rare: bronchospasm (inhaled form)
⚠ Long-term use may deplete zinc stores

Interações Conhecidas

● Nitroglycerin (may enhance hypotensive effects)
● Activated charcoal (reduces NAC absorption)
● Anticoagulants (theoretical interaction)

Ingestão máxima tolerável: Not established as supplement; 6,000+ mg/day used clinically (IV)

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Depression-Related Cognitive Dysfunction?

Based on 6 studies with 400 participants, there is limited but promising evidence that N-Acetyl Cysteine may support Depression-Related Cognitive Dysfunction management. Our evidence grade is C (Some Evidence).

How much N-Acetyl Cysteine should I take for Depression-Related Cognitive Dysfunction?

Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of N-Acetyl Cysteine?

Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for N-Acetyl Cysteine and Depression-Related Cognitive Dysfunction?

We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Outros ingredientes para Depression-Related Cognitive Dysfunction

Omega-3 Fatty Acids (DHA/EPA) B Vitamin D C

N-Acetyl Cysteine para outras condições

Oxidative Stress & Neuroinflammation B Post-Concussion Cognitive Symptoms B

Veredito Rápido

Evidence Strength52%

Moderate confidence

Detalhamento dos Estudos

RCT (0)Meta (0)Other (6)

Comparar Alternativas

Veja como outros ingredientes se comparam para esta condição.

Ver todos os ingredientes para Depression-Related Cognitive Dysfunction

Saiba Mais

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.